The same genetic variants that have been uncovered in patients with two other types of cardiomyopathy are also present in an uncommonly high proportion of people with cancer therapy-induced cardiomyopathy (CCM), researchers reported in Circulation.

Using dynamic contrast-enhanced MRI, researchers found quantitatively mapping a patient’s blood-brain barrier dysfunction (BBBD) may be valuable for risk stratification and stroke prevention after a transient ischemic attack (TIA).

An AI platform designed to quickly read an x-ray and determine the manufacturer and model of a cardiac rhythm device may quicken treatment in the event of device failure.

The International Contrast Ultrasound Society (ICUS) is again urging the FDA to remove the “black box” warning from ultrasound contrast agent (UCA) labels, following its filing of a September 2018 citizen petition with the federal agency.

Researchers used T2 mapping taken from weekly cardiac MRIs to help identify cardiotoxicity at an early stage, according to results of a pig study published Feb. 18 in the Journal of the American College of Cardiology. The findings could help cancer patients at risk of chemo-induced heart failure.

T2 mapping derived from weekly cardiac MRIs helped researchers identify cardiotoxicity at an early and reversible stage, a finding which may have implications for cancer patients at risk of chemotherapy-induced heart failure.

Autosomal dominant polycystic kidney disease (ADPKD) is among the most common hereditary diseases and is associated with complications such as intracranial aneurysm. A lack of screening guidelines prompted a group of researchers to evaluate the cost-effectiveness of various MR angiography strategies.

Stress cardiac MRI (CMR) greatly improved the accuracy of mortality prediction in patients with known or suspected coronary artery disease (CAD), reported authors of a large, multi-center study published in JAMA Cardiology.